The prognostic value of these 'hormonal environmental' markers in TNBC may also be related in part to tumor heterogeneity, reinforcing the hypothesis that variation in ER, PR, and HER2 status between primary breast cancer and metastases [42] may actually reflect clonal genome evolution. The gene discussed is ESR1; the disease is breast cancer.